© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Sulfanilamide opened the floodgates for modern antibiotics. Chemists discovered its bacteria-fighting power by accident, tracing roots back to early 1900s German dye factories. Scientists tinkered with coal-tar dyes looking for colorants, and products like sulfanilamide slipped into the spotlight after German researchers linked dye components to bacterial growth suppression. The true breakthrough came in the 1930s. Domagk's Prontosil, a red dye, rescued his own daughter from a deadly infection, catching medical attention when scientists realized sulfanilamide was the active part at work. This wasn’t just a fluke; it established that chemical intervention could flatten deadly bacteria before penicillin ever found its limelight.
Sulfanilamide, now an archetype for sulfa drugs, uses its straightforward structure to stand out among pharmaceuticals. Packagers sell it as a white crystalline powder, recognizable and easily handled. Early on, pills and ointments helped treat everything from strep throat to wound infections. Over-the-counter versions quickly faded as risks became clear. Yet, sulfanilamide still carves a niche in select formulations and research kits even as penicillins and cephalosporins push it aside in most prescriptions.
Sulfanilamide shows up as odorless, slightly soluble in water but more so in alcohol. Its melting point clocks around 165 degrees Celsius. The molecular structure includes an aniline ring with a sulfonamide group, making it easy for organic chemists to diagram. With a formula of C6H8N2O2S, its simplicity hides the punch it delivers against microorganisms. Acidity stems from its sulfonamide group, which helps decide how it interacts with both bacteria and solvents. It won’t ignite easily, but it does degrade under harsh heat, giving lab handlers clear storage instructions.
Regulations demand clear technical records and labeling for sulfanilamide. Purity standards rarely drop below 99%. Packagers list batch numbers, storage conditions (cool, dry, away from light), grade (pharmaceutical or research), and hazard warnings such as “harmful if swallowed” or “possible allergen.” Medical vials and tablets label both chemical and brand names, with strengths measured in milligrams or percentages for creams. Labels trace sources and batch testing, so hospitals can respond quickly to contamination scares—an ongoing lesson from the 1937 tragedy when a contaminated sulfanilamide-based elixir killed dozens, shaping drug safety rules for decades.
Chemists build sulfanilamide from aniline using sulfonation and amination steps. Factories feed aniline through sulfuric acid, then neutralize it to attach a sulfonic acid group in the para position. Amination through ammonia introduces the second nitrogen, completing the molecule. Each step needs close temperature and pH control to dodge dangerous side-products and ensure consistent yields. Modern reactors allow scale-up for mass production, letting drugmakers whip up hundreds of kilograms in days. Labs must monitor waste streams for hazardous salts and residual acids, since both create regulatory headaches.
Chemists juggle sulfanilamide as a core scaffold for wider sulfa drug families. Its para-amino group accepts acetyl or other side chains, creating drugs like sulfadiazine or sulfamethoxazole. This versatility echoes in laboratory recipes, letting chemical teams design new analogs to combat drug resistance. Reaction with oxidants can break down sulfanilamide for disposal or degradation studies. Simple analytical reactions—like color change with diazotization—let technicians check for purity without heavy lab equipment. The functional groups make it a prime candidate when searching for new therapies in chemical libraries.
Sulfanilamide cycles through many aliases in chemical commerce: para-aminobenzenesulfonamide, 4-aminobenzenesulfonamide, its historical German patent designations, and English trademarks like Streptocide or Prontosil-S. Prescription forms lump it with others simply as “sulfa drugs”. Local labeling codes may differ, but each name points back to the same molecular backbone. Pharmacopeias in Europe, Asia, and the US require harmonized names so no confusion stalls critical shipments or recalls.
Sulfanilamide prompted some of the strictest drug regulations in history after the elixir disaster. The 1938 Federal Food, Drug, and Cosmetic Act imposed pre-market safety screening in the US. Manufacturing plants now need HVAC systems to contain dust, protective clothing for workers, and spill protocols that neutralize or collect residues for hazardous waste handling. Technicians watch for skin and respiratory irritation—labs require fume hoods and glove use. Tablet production lines regularly audit hygiene and cleaning standards to prevent cross-contamination. Pharmacies stock safety data sheets alongside inventory for quick reference.
Doctors prescribed sulfanilamide for bacterial infections long before penicillin reached mass production. It worked for pneumonia, tonsillitis, urinary tract infections, meningitis, and even as dust in wound dressings in World War II. In dentistry, topical sulfanilamide creams treat mouth ulcers and postoperative infections. Veterinary uses haven’t faded as quickly—in rural medicine, it remains a fallback when resistance rules out newer drugs. Research circles value sulfanilamide for probing bacterial enzyme inhibition. Its quirks even help train future pharmacists and analytical chemists on basic compound testing and formulation.
Drug researchers still tinker with sulfanilamide-based molecules. Resistance threatens most antibiotics, so teams look for chemical tweaks that breathe new life into old drugs. In the 21st century, institutions use computer modeling to find sulfanilamide derivatives with selective action. Some researchers aim for anti-cancer or anti-inflammatory effects, not just antimicrobial. Process engineers hunt cheaper or safer syntheses that skip hazardous reagents or byproducts. The search for combined therapies—pairing sulfanilamide with enzyme blockers or delivery nanoparticles—remains a busy line of inquiry. Journals flood with papers comparing it to newer options, mapping its continued use in low-resource settings.
Toxicologists dig deep into sulfanilamide’s hazards. The infamous diethylene glycol poisoning stamped public awareness on the need for solvent safety, not just drug safety. Allergic reactions—rashes, fevers, even life-threatening Stevens-Johnson syndrome—forced clinics to scan patient histories before prescribing. Sulfanilamide’s metabolic breakdown sometimes leads to kidney stones or liver strain, especially with long-term use. Testing labs dose rodents to set human safety margins, with regulators constantly updating acceptable daily intake limits. In fish and wildlife protection, sulfanilamide runoff from farms raises red flags for environmental risk, prompting studies on biodegradation and treatment systems.
The future for sulfanilamide isn’t about blockbuster sales; it revolves around targeted roles and backup planning. Drug companies keep it in reserve for outbreaks in areas where resistance to newer antibiotics spreads fast and generic penicillins cost too much. The pipeline for re-engineered sulfanilamide derivatives chugs on, each tweak adjusting solubility or selectivity to dodge resistance. In medical education, classic drugs like sulfanilamide remain useful teaching tools for understanding the science behind how antibiotics disrupt bacterial metabolism. Conservation in use matches growing policies to guard antibiotic effectiveness for future generations. In the right hands, with careful oversight, sulfanilamide still offers answers for some of medicine’s trickiest problems.
Sulfanilamide doesn’t show up in every conversation about antibiotics, yet it played an enormous part in shaping the way doctors handle infections. My grandfather, who barely talks about his time growing up before antibiotics, used to recall stories of people lost to common infections. When sulfanilamide arrived, hospitals finally started fighting back against those bacterial threats that once meant a near-certain death sentence.
Sulfanilamide belongs to a family of drugs called sulfa drugs. These drugs target and slow down the growth of bacteria. If you look at the years before penicillin, injuries from farming or working in factories often led to fatal infections. Surgeons and soldiers both counted on sulfanilamide powder and tablets to cut down deadly wound infections, especially during the 1930s and World War II.
Doctors prescribe sulfanilamide mainly for urinary tract infections and sometimes for vaginal infections. It still gets a mention in some textbooks as a treatment option for certain types of meningitis and pneumonia caused by sensitive bacteria. The drug works well against Streptococcus and some strains of Staphylococcus, and it’s effective against some rarer bacteria. While not a top choice today, mainly due to resistance and better-tolerated drugs, its impact lingers.
Public trust took a hit in the 1930s with the “Elixir Sulfanilamide” disaster. More than 100 people died after a manufacturer mixed the drug with a toxic solvent. That tragedy set the stage for the Food, Drug, and Cosmetic Act of 1938, a law that forced companies to actually prove safety. From a safety perspective, even today, this story remains a warning about shortcuts and why oversight matters in the pharmacy world.
While newer antibiotics mostly replaced the drug by the 1950s and 60s, sulfanilamide didn’t vanish. Some people react badly to penicillin; for them, doctors might still reach for sulfa drugs. They also pop up in developing areas where cost or access means older drugs remain valuable. Plus, these medicines are used in creams to treat burn wounds, discouraging infections where modern antibiotics might be unaffordable.
No honest conversation about sulfanilamide skips the side effects. Rashes, fever, and kidney issues—these reactions push many toward newer options. Some populations, like folks with G6PD deficiency, should avoid sulfanilamide altogether due to risk of severe problems. Doctors want to minimize harm, so care and screening matter before picking this drug.
Modern labs keep an eye on resistance patterns. Doctors depend on sensitivity testing to pick an antibiotic that works, both to avoid failure and to slow the march of resistance. The world saw what happened when drugs stopped working—outbreaks of infections doctors thought were history. Sulfanilamide’s decline wasn’t about forgetting an old drug, but about learning, changing, and constantly searching for safer, more effective answers.
Today, if you have access to newer antibiotics, you probably won’t get a prescription for sulfanilamide. For many people worldwide, though, it’s still part of the arsenal. Its history stands as a sharp reminder: bold new ideas in science can save millions when supported by careful testing, respect for patient safety, and vigilance around real-world effects.
Sulfanilamide doesn’t pop up often in casual conversation, yet its story changed the way people look at antibiotics. Discovered in the 1930s, it fought off bacterial infections before penicillin grabbed the spotlight. I still remember hearing about the tragic events of the 1937 “Elixir Sulfanilamide” disaster, where poor drug formulation led to more than 100 deaths and helped spark the birth of the FDA’s drug safety oversight. That history shaped a lifelong skepticism about cutting corners with medicines—especially ones as powerful as sulfanilamide.
For oral use, sulfanilamide comes in tablet or powdered form. I’ve seen doctors recommend swallowing with water after food, as this helps with stomach tolerance. Drinking plenty of water is crucial. It’s not just about comfort—enough water can lower the risk of kidney stones, which sulfa drugs sometimes trigger. Missing water might leave crystals in the kidneys, and that’s pain you never forget.
People often underestimate the risk of skipping doses or taking a double dose to “catch up.” That move won’t heal an infection faster; it just increases the odds of side effects. Stick to the prescribed schedule, and finish each course, even if you feel better halfway through.
Doctors sometimes watch skin wounds carefully, especially in folks who tend to get infections. Sulfanilamide powder and ointment play a role here, often sprinkled or applied to burns, scrapes, or ulcers to help ward off bacteria. A gentle hand during application matters—clean wounds first, wash your hands, then use a clean applicator or sterile gauze to apply the medicine. Resist the urge to slather it on thick, since extra medicine won’t boost effectiveness and could delay healing.
Cover the treated area with a sterile bandage if needed. If you start seeing signs of irritation, redness, or allergic reactions, reach out to a doctor. That classic sulfa rash is something no one wants to deal with at home.
Not everyone can take sulfa drugs safely. People with a history of sulfa allergies need to steer clear. I’ve lost count of the number of times patients forgot to mention allergies until a rash erupted. That small detail saves a lot of trouble. Let your doctor know about every medicine you take, whether prescription, over-the-counter, or herbal. Sulfanilamide doesn’t always play nice with other drugs, especially blood thinners or diabetes medicine.
People sometimes hope for quick fixes with antibiotics. That mindset can backfire. Health risks from misuse—like resistance, severe allergic reactions, or kidney problems—tip the scales. If there’s ever a question about the right dose, application, or side effects, pharmacists and doctors are just a call away. In my experience, those quick chats can save weeks of misery or worse.
Proper care transforms this old drug from a relic into a reliable tool. Its benefits rely on informed use, honest conversations with health professionals, and respect for your own health history.
Sulfanilamide played a huge role in early antibiotic history. Doctors once reached for it to fight infections before better options showed up. Some people still remember stories from parents or grandparents about its heyday. These days, folks don’t see sulfanilamide on a pharmacy shelf, but lessons from its past matter because the problems it caused shaped modern drug safety laws. People need to understand what happens when the body reacts badly to drugs like this.
Reactions can set in faster than expected. Rashes, swelling, or even trouble breathing tell you something’s gone wrong. Hives itch and spread. Lips or face might puff up. For some, sulfanilamide triggers full-on anaphylaxis, bringing on a drop in blood pressure and problems pulling in air. Doctors respect these risks, not just because they read about them, but because phone calls about sudden symptoms stick in their memory long after the patient’s gone home. A handful of people deal with Steven-Johnson syndrome, a rare but severe response with skin peeling and life-threatening pain. That fear keeps hospitals alert every time someone reports a rash with sore mouth ulcers or blisters.
Sulfanilamide doesn’t pick just one part of the body to challenge. Sometimes it attacks blood cells, lowering the number of healthy red cells and causing anemia. My old med school professor loved showing a jar filled with yellowish plasma, pointing out what happens when hemolysis ramps up. Folate deficiency creeps in, leading to weakness or fatigue that drags on and on. In rare cases, the immune system mixes up its signals and destroys blood cells in a disease called agranulocytosis, leaving people open to other infections. Some nights on call, you see kidney stones block up the urinary tract after sulfa drug use. Patients double over in pain. Blood turns up in urine. Crystals silently form and scrape at internal tissues. There’s also a risk of hepatitis—jaundice, dark urine, and stomach pain tell their own story about liver stress.
Even with proper doses, some patients suffer. Genes or allergies matter as much as pill counts. I once met a patient who’d taken sulfanilamide as a child and still shuddered at the memory, not because the infection was bad, but because weeks later her skin still peeled and cracked. Her experience makes it obvious: doctors and patients—especially with family histories of allergies—should weigh other options when possible.
The sulfanilamide tragedy of the 1930s, which led to hundreds of deaths, pushed lawmakers to demand proof of safety before drugs hit the market. The scars left by those events keep the FDA on their toes. Real-time reporting of side effects and open doctor-patient conversations protect more people from repeating the same mistakes. Today, patients speak up sooner. Good pharmacists check for drug allergies twice, not once. Patients have every right to ask about side effects before starting anything new, especially an antibiotic or any medication with a checkered history. Respect for the past helps pave a safer road for future treatments.
Sulfanilamide rings a bell for anyone who’s read the history of antibiotics. This medication, one of the earliest sulfa drugs, helped shape modern medicine by fighting bacterial infections before penicillin entered the stage. But the story changes when the conversation shifts to pregnancy or breastfeeding. Families and medical professionals keep asking the same question: can women safely use sulfanilamide during these sensitive times?
Pregnancy and breastfeeding are times packed with doctor visits, blood tests, and reading every label twice. Expecting mothers already juggle enough worries, so having clear answers about medication brings some peace of mind. Here, everything placed in the body, from a cup of coffee to antibiotics, carries risks and benefits. One visit to the pharmacy can leave anyone overwhelmed by the fine print and bright warning labels.
Pregnant women face infection risk just like anyone else but medicine behaves differently during pregnancy. The placenta, a lifeline for growing babies, doesn’t always block out what’s harmful. Some drugs cross over easily. Studies show that sulfonamides, which include sulfanilamide, slip through and can reach the baby’s bloodstream. In babies, especially during the first trimester, this can lead to serious complications—a fact that sticks with me after reading about cases where newborns developed jaundice or birth defects linked to medication exposure.
Sulfanilamide has a checkered safety record. One of the biggest disasters in American medicine came from sulfanilamide back in the 1930s, when a poorly made preparation killed over a hundred people. That tragic event helped launch the FDA’s strong drug approval laws. Today, the medication itself is safer, but the real concern surrounds its side effects in pregnancy and nursing.
Based on modern research, sulfanilamide shows a risk for newborns, especially if given late in pregnancy. The drug can cause a condition named kernicterus, where bilirubin builds up in the baby’s brain from displaced proteins in the blood. This isn’t common, but one case is too many for parents. During breastfeeding, the drug gets into breast milk, and although levels tend to be low, newborns—especially those born prematurely—do not handle these compounds the same way adults do. Health authorities like the CDC and American Academy of Pediatrics urge caution for this reason.
Doctors look for safer alternatives because the risks pile up fast with sulfanilamide. Current guidelines often recommend penicillins or certain cephalosporins for infections in pregnant women since these options don’t pose the same risks. I’ve listened to mothers who worried through those nine months, weighing the infection against the fear of drug side effects. They depended on open conversations with trustworthy health professionals—not just what’s written on the medication leaflet or found with a quick online search.
No one wants to gamble with pregnancy or a newborn’s health. Having been close to people in this situation, I see that reassurance comes from understanding facts and knowing there are choices. Asking questions, reviewing medication history with doctors, and pushing for the latest research gives parents the best shot at keeping their families safe. For sulfanilamide, most medical advice holds firm: avoid it in pregnancy and breastfeeding when safer medicines exist.
Most folks won’t remember Sulfanilamide off the top of their head. This antibiotic once sparked a huge medical breakthrough back in the early 20th century, saving lives during an era when common infections could turn deadly. Today, it still shows up for tough infections, though it’s not a household name. Like many older medicines, it comes with baggage—often set off by what’s sitting on your bathroom shelf or prescribed for another reason. That’s the part that deserves attention, because mixing medications without thinking twice can stir up trouble in unexpected ways.
I used to help stock medications at a local pharmacy for several summers. Folks would arrive with lists: painkillers, diabetes meds, blood thinners, antidepressants, and antibiotics. Pharmacists always scanned for anything that didn’t belong together. There’s good reason. Sulfanilamide interacts with a surprisingly long list of everyday drugs.
Take blood thinners like warfarin. If these team up with Sulfanilamide, patients might notice more bruising, purple splotches, or even unexplained bleeding. The antibiotic slows the breakdown of the thinner, making it harder for the body to keep blood just the right consistency. That’s not a classroom lesson; I’ve seen worried patients and even had to call a family member once to pick up their grandmother after she fainted because her blood got too thin.
Diabetic patients get a different headache. Some drugs for managing blood sugar, like sulfonylureas, compete for the same pathways as Sulfanilamide. The clash can sneakily lower blood sugar, which shows up as cold sweats, hunger, or confusion—not fun for anyone trying to work or care for their kids.
Pain meds and anti-inflammatories, such as aspirin, can make side effects worse too. People sometimes forget to mention the aspirin they pop for a headache, but Sulfanilamide can intensify kidney strain, piling extra work on an organ that doesn’t always show problems until it’s too late.
The best defense comes from a little honesty and conversation. Some believe doctors and pharmacists automatically spot every risk, but the truth is, medical systems don’t always catch everything. People bounce between specialists or try new over-the-counter pills without always telling each prescriber. Something as innocent as an herbal supplement or a pain reliever can derail a treatment plan if mixed with an antibiotic like Sulfanilamide.
Trust is the glue here—trust with your health care provider, and trust in your own voice. Keeping a list of every medication and supplement helps. Carrying that list or storing it in a phone app—especially for older adults or anyone with complex health needs—can make all the difference during an ER visit or routine check-up.
Doctors and pharmacists want the details. They rely on patients to fill in the blanks. If things feel off, it’s wise to call, not wait for something scarier. Most people I’ve helped over the years realized after a scare that asking—even if it seemed like a silly question—could save a hospital trip or prevent long-term damage.
Sulfanilamide is a useful tool, but it stands as a reminder that mixing medications deserves more than a shrug. Open conversation and a little planning protect lives in real, everyday ways. Maybe this approach, more than the chemical formula, should shape how we think about all kinds of medicines in the future.
| Names | |
| Preferred IUPAC name | 4-aminobenzenesulfonamide |
| Other names |
p-Aminobenzenesulfonamide 4-Aminobenzenesulfonamide Streptocide |
| Pronunciation | /ˌsʌl.fəˈnɪl.ə.maɪd/ |
| Identifiers | |
| CAS Number | 63-74-1 |
| 3D model (JSmol) | 'Sulfanilamide' 3D model (JSmol) string: ``` CC1=CC=C(C=C1)S(=O)(=O)N ``` This is the SMILES string for Sulfanilamide, which can be used to generate a 3D model in JSmol or similar molecular viewers. |
| Beilstein Reference | 1145053 |
| ChEBI | CHEBI:9075 |
| ChEMBL | CHEMBL22 |
| ChemSpider | 2121 |
| DrugBank | DB00259 |
| ECHA InfoCard | 045e1962-526a-443e-8a25-88fdf74689ea |
| EC Number | 200-615-1 |
| Gmelin Reference | 82193 |
| KEGG | C07361 |
| MeSH | D013436 |
| PubChem CID | 5321 |
| RTECS number | WO4900000 |
| UNII | 7M19D7RBW5 |
| UN number | 2811 |
| Properties | |
| Chemical formula | C6H8N2O2S |
| Molar mass | 172.20 g/mol |
| Appearance | White, odorless crystalline powder |
| Odor | Odorless |
| Density | 1.08 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | -0.62 |
| Vapor pressure | 1.39E-07 mmHg at 25°C |
| Acidity (pKa) | 10.4 |
| Basicity (pKb) | 1.00 |
| Magnetic susceptibility (χ) | -78.0 × 10^-6 cm³/mol |
| Dipole moment | 3.91 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 237.8 J⋅mol⁻¹⋅K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | –356.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -4116 kJ mol⁻¹ |
| Pharmacology | |
| ATC code | J01EB03 |
| Hazards | |
| Main hazards | Harmful if swallowed; may cause allergic skin reaction; causes serious eye irritation. |
| GHS labelling | GHS07, Warning, H315, H319, H335 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | P264, P270, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 2-1-0 |
| Flash point | 146°C |
| Autoignition temperature | 540 °C |
| Lethal dose or concentration | LD50 (oral, rat): 2,500 mg/kg |
| LD50 (median dose) | LD50 (median dose): 2,500 mg/kg (oral, rat) |
| NIOSH | WN6500000 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Sulfanilamide: Not established |
| REL (Recommended) | 0.01 mg/L |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds |
Sulfadiazine Sulfathiazole Sulfapyridine Sulfamethoxazole Sulfacetamide |
